Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein

by Andrey Rekstin, Irina Isakova-Sivak, Galina Petukhova, Daniil Korenkov, Igor Losev, Tatiana Smolonogina, Tatiana Tretiak, Svetlana Donina, Svetlana Shcherbik, Tatiana Bousse, Larisa Rudenko
Published 2017-01-01

Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.

by Svetlana Shcherbik, Nicholas Pearce, Amanda Balish, Joyce Jones, Sharmi Thor, Charles Todd Davis, Melissa Pearce, Terrence Tumpey, David Cureton, Li-Mei Chen, Julie Villanueva, Tatiana L Bousse
Published 2015-01-01

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

by Svetlana Shcherbik, Nicholas Pearce, Paul Carney, Ekaterina Bazhenova, Natalie Larionova, Irina Kiseleva, Larisa Rudenko, Amrita Kumar, Cynthia S. Goldsmith, Vivien Dugan, James Stevens, David E. Wentworth, Tatiana Bousse
Published 2019-08-01